Market closed

TriSalus Life Sciences, Inc./$TLSI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About TriSalus Life Sciences, Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Ticker

$TLSI
Trading on

Industry

Biotechnology

Employees

116

TLSI Metrics

BasicAdvanced
$163M
-
-$1.31
0.48
-
$163M
0.48
$5.83
$4.60
2.021
1.331
-90.419
-91.253
-11.70%
-90.97%
115.93%
4.493
-6.31
-6.31
58.99%
-80.52%
51.88%
-26.13%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TLSI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for TriSalus Life Sciences, Inc. stock?

TriSalus Life Sciences, Inc. (TLSI) has a market cap of $163M as of April 05, 2025.

What is the P/E ratio for TriSalus Life Sciences, Inc. stock?

The price to earnings (P/E) ratio for TriSalus Life Sciences, Inc. (TLSI) stock is 0 as of April 05, 2025.

Does TriSalus Life Sciences, Inc. stock pay dividends?

No, TriSalus Life Sciences, Inc. (TLSI) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next TriSalus Life Sciences, Inc. dividend payment date?

TriSalus Life Sciences, Inc. (TLSI) stock does not pay dividends to its shareholders.

What is the beta indicator for TriSalus Life Sciences, Inc.?

TriSalus Life Sciences, Inc. (TLSI) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.